The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BSH 2022 | Using prehabilitation to improve patient outcome post-transplant
Keith Wilson, MBBS, FRCP, FRCPath, Cardiff University, Cardiff and Vale University Health Board, Cardiff, Wales discusses the benefits of using prehabilitation to improve patient outcome and response following transplantation. Dr Wilson first explains that frailty can be improved in the elderly population using prehabilitation, and then further explains an upcoming project in his clinic which aims to investigate the impact of prehabilitation in younger patients undergoing transplantation, and whether this will improve patient outcome as well as potentially reduce the cost of post-treatment care. This interview took place at the 62nd Annual Scientific Meeting of the British Society for Haematology (BSH) 2022, in Manchester, UK.
